The invention relates to pharmaceutical compounds of formula (I) and pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds as inhibitors of cyclin-dependent kinase 7 (CDK7) and to their use in the treatment of diseases, e.g., cancer.
本发明涉及公式(I)的药物化合物和包含该化合物的药物组合物,涉及制备该化合物的过程以及将该化合物用作细胞周期素依赖性激酶7(CDK7)的
抑制剂并用于治疗疾病,例如癌症。